Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection.
1,2,3-Dithiazoles
Feline Immunodeficiency Virus (FIV)
Human Immunodeficiency Virus (HIV)
Nucleocapsid protein
Zinc ejection
Journal
Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298
Informations de publication
Date de publication:
15 08 2022
15 08 2022
Historique:
received:
29
04
2022
revised:
13
05
2022
accepted:
13
05
2022
pubmed:
3
6
2022
medline:
29
6
2022
entrez:
2
6
2022
Statut:
ppublish
Résumé
We disclose a series of potent anti-viral 1,2,3-dithiazoles, accessed through a succinct synthetic approach from 4,5-dichloro-1,2,3-dithiazolium chloride (Appel's salt). A series of small libraries of compounds were screened against feline immunodeficiency virus (FIV) infected cells as a model for HIV. This approach highlighted new structure activity relationship understanding and led to the development of sub-micro molar anti-viral compounds with reduced toxicity. In addition, insight into the mechanistic progress of this system is provided via advanced QM-MM modelling. The 1,2,3-dithiazole represents a versatile scaffold with potential for further development to treat both FIV and HIV.
Identifiants
pubmed: 35653871
pii: S0968-0896(22)00226-7
doi: 10.1016/j.bmc.2022.116834
pii:
doi:
Substances chimiques
Antiviral Agents
0
Nucleocapsid Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
116834Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.